Skip to content

EyePoint, Inc. EYPT Market capitalization

Market capitalization at other companies

Merck & Co. logo
Merck & Co.MRK
$297.4B+31.2%
Regeneron Pharmaceuticals logo
Regeneron PharmaceuticalsREGN
$81.68B+17.8%
Ocular Therapeutix logo
Ocular TherapeutixOCUL
$1.84B+58.2%
Kodiak Sciences Inc logo
Kodiak Sciences IncKOD
$2.33B+1,477%
HRO
HarrowHROW
$1.31B+38.4%
Ultragenyx Pharmaceutical logo
Ultragenyx PharmaceuticalRARE
$2.06B-39.4%

Other financials

Income statement

See full
Revenue$696.0K-97.2%
Gross profit$9.8M-30.1%
Operating income-$87.2M-78.6%
Net income-$84.8M-87.7%
EPS (diluted)-$0.99-52.3%

Balance sheet

See full
Cash & equivalents$77.7M-8.7%
Total debt$22.3M-7.3%
Total equity$230.5M-22.8%
Total assets$288.2M-20.5%

Cash flow

See full
Operating cash flow-$80.5M-51.6%
CapEx$997.0K+261%
Free cash flow-$81.5M-52.7%

Valuation

See full
Enterprise value$1.15B+228%
P/S158.5×+151×

Profitability

See full
Operating margin-3,700.9%-4,042pp
Net margin-3,566.6%-3,874pp
FCF margin-3,565.9%-3,884pp

Returns & leverage

See full
Return on equity-102.7%+1,157pp
Debt / equity0.1×0.0×
Current ratio6.7×-1.2×

Where this comes from

Computed from the period-end share price: $1.08B.

The official record: EyePoint, Inc. ’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about EyePoint, Inc. 's market capitalization.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is EyePoint, Inc. 's market capitalization?
EyePoint, Inc. (EYPT) reported market capitalization of $1.08B in Q1 2026.
How has EyePoint, Inc. 's market capitalization changed year-over-year?
EyePoint, Inc. 's market capitalization increased by 188.7% year-over-year, from $372.51M to $1.08B.
What is the long-term trend for EyePoint, Inc. 's market capitalization?
Over 5 years (2020 to 2025), EyePoint, Inc. 's market capitalization has grown at a 46.6% compound annual growth rate (CAGR), from $223.06M to $1.51B.
What does market capitalization mean?
The total market value of the company's equity at the quarter end (share price × shares outstanding), sampled from daily market data. The latest point tracks the live price.